Whole-Body Diffusion-weighted Mr imaging for assessment of Treatment r esponse in

[1]  Celia P. Corona-Villalobos,et al.  Agreement and Reproducibility of Apparent Diffusion Coefficient Measurements of Dual-b-Value and Multi-b-Value Diffusion-Weighted Magnetic Resonance Imaging at 1.5 Tesla in Phantom and in Soft Tissues of the Abdomen , 2013, Journal of computer assisted tomography.

[2]  G. Morgan,et al.  Assessing response of myeloma bone disease with diffusion-weighted MRI. , 2012, The British journal of radiology.

[3]  D. Collins,et al.  Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. , 2012, AJR. American journal of roentgenology.

[4]  Namkug Kim,et al.  Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: Effect of DWI techniques and calculation methods , 2012, Journal of magnetic resonance imaging : JMRI.

[5]  D. Hose,et al.  Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma , 2012, Haematologica.

[6]  T. Derlin,et al.  Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation , 2012, European Radiology.

[7]  C. Claussen,et al.  Modern imaging techniques during therapy in patients with multiple myeloma , 2011, Acta radiologica.

[8]  D. Collins,et al.  Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging--value of histogram analysis of apparent diffusion coefficients. , 2011, Radiology.

[9]  P. Choyke,et al.  Current and future imaging modalities for multiple myeloma and its precursor states , 2011, Leukemia & lymphoma.

[10]  G. Morgan,et al.  Guidelines for the diagnosis and management of multiple myeloma 2011 , 2011, British journal of haematology.

[11]  H. Goldschmidt,et al.  Diffusion‐weighted imaging for non‐invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology , 2011, British journal of haematology.

[12]  M. Dimopoulos,et al.  Advances in imaging and the management of myeloma bone disease. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Hartmut Goldschmidt,et al.  Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. , 2011, Blood.

[14]  M. Dimopoulos,et al.  Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1. , 2011, Blood.

[15]  D. Collins,et al.  Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility , 2011, European Radiology.

[16]  K. Scheffler,et al.  Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression , 2011, European Radiology.

[17]  C. Claussen,et al.  Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility study. , 2010, Academic radiology.

[18]  M. Gertz.  review: Current status of stem cell mobilization , 2010, British journal of haematology.

[19]  Christopher J. Hanrahan,et al.  Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  Martin O. Leach,et al.  Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial , 2009, European Radiology.

[21]  S. Delorme,et al.  Imaging in multiple myeloma. , 2009, European journal of radiology.

[22]  E Terpos,et al.  International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma , 2009, Leukemia.

[23]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[24]  R. Gonzalez,et al.  Improved Detection of Skull Metastasis with Diffusion-Weighted MR Imaging , 2007, American Journal of Neuroradiology.

[25]  B. Barlogie,et al.  International uniform response criteria for multiple myeloma , 2006, Leukemia.

[26]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[27]  R. Fletcher,et al.  Clinical Epidemiology: The Essentials , 1982 .